Financial Performance - Revenue for the three months ended March 27, 2020, was 3,731,559,adecreaseof6.73,999,987 for the same period in 2019[6]. - Net loss attributable to Aramark stockholders for the three months ended March 27, 2020, was (202,260),comparedtonetincomeof29,353 for the same period in 2019[6]. - Operating loss for the three months ended March 27, 2020, was (97,676),asignificantdeclinefromoperatingincomeof122,835 in the prior year[6]. - Comprehensive loss attributable to Aramark stockholders for the three months ended March 27, 2020, was (310,505),comparedtoacomprehensiveincomeof20,698 in the same period last year[9]. - Total revenue for the six months ended March 27, 2020, was 7,985.2million,down3.48,265.3 million in the prior year[51]. - The company experienced a net loss of (56,138)forthesixmonthsendedMarch27,2020,comparedtoanetincomeof279,988 for the same period in 2019[10]. - The company reported a net cash used in investing activities of (196,588)million,contrastingwith58,195 million provided in the prior year[12]. - The company reported a comprehensive income of 229,609,000attributabletoAramarkstockholders[92].GoodwillImpairment−Thecompanyreportedagoodwillimpairmentof198,600 for the three months ended March 27, 2020, indicating potential challenges in asset valuation[6]. - The company recognized a non-cash impairment charge of 198.6millionduetoadeclineinfairvalueofareportingunit,withtheremaininggoodwillbalanceforthatunitat86.2 million[30]. - Goodwill impairment recorded was 198,600forthesixmonthsendedMarch27,2020[88].−Thecompanyincurred198.6 million in goodwill impairment during the three months ended March 27, 2020, compared to no impairment in the same period last year[106]. COVID-19 Impact - The company anticipates ongoing challenges due to the impact of COVID-19 on its operations and financial performance, which may affect future earnings and strategic initiatives[5]. - The COVID-19 pandemic is estimated to have impacted revenue by 325millionandoperatingincomeby70 million for the three and six months ended March 27, 2020[101]. - The total decline in revenue related to COVID-19 was estimated at approximately 325million,impactingrevenuebyapproximately3.92,231.1 million, a decline of 7.7% from 2,417.0millioninthesameperiodlastyear[51].−FSSInternationalsegmentrevenueforthethreemonthsendedMarch27,2020,was853.5 million, down 9.4% from 942.0millionintheprioryear[51].−TheFSSUnitedStatessegmentreportedrevenueof2,231.1 million, down from 2,417.0million,reflectingadeclineof7.7853.5 million from 942.0million,representingadecreaseof9.4(91,626) million, a significant decrease from 88,983millionprovidedintheprioryear[12].−Cashandcashequivalentsattheendoftheperiodincreasedto1,202,964 million, compared to 195,387millionattheendofthepreviousyear[12].−Thecompanyhadapproximately1,203.0 million in cash and cash equivalents and 4.7millionavailableundertheseniorsecuredrevolvingcreditfacilityasofMarch27,2020[36].−Thecompanyundertookborrowingsof948.8 million under its revolving credit facility and 400.0millionunderitsReceivablesFacilityinresponsetoCOVID−19[122].ShareholderActions−Thecompanypaidcashdividendsofapproximately55.3 million during the six months ended March 27, 2020[65]. - The company repurchased 0.3 million shares of common stock for 6.5millionduringthesecondquarteroffiscal2020[65].−Thecompanyauthorizedanewsharerepurchaseprogramofupto200.0 million, which will expire in July 2022[128]. Tax and Financing - The company recorded an income tax expense of approximately 3.7millionforboththethreeandsixmonthperiodsoffiscal2020[64].−TheeffectivetaxrateforthethreeandsixmonthsendedMarch27,2020includestaxbenefitsofapproximately26.9 million and 45.5millionduetoexcesstaxbenefitsfromequityawards[64].−InterestandotherfinancingcostsforthethreemonthsendedMarch27,2020,increasedto99,822 from 84,178inthesameperiodlastyear,representingan18.51,500.0 million aggregate principal amount of 6.375% Senior Notes due May 1, 2025, with net proceeds intended for general corporate purposes[39].